Trelagliptin succinate

CAS No. : 1029877-94-8

Trelagliptin succinate,1029877-94-8
Product Details
For research use only. Not Intended for Therapeutic Use!
Cat No:I000181
Synonyms:2-[[6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxopyrimidin-1-yl]methyl]-4-fluorobenzonitrile;butanedioic acid
Molecular Formula:C₂₂H₂₆FN₅O₆
Molecular Weight:475.47
Price:Get quote
We would like to match the lowest price on market if possible.

Your information is safe with us.

Cat No:I000181
Cas No:1029877-94-8
Product-Name:Trelagliptin succinate

Trelagliptin(SYR-472) is a long acting dipeptidyl peptidase-4 (DPP-4) inhibitor that is being developed for the treatment of type 2 diabetes (T2D).
IC50 value:
Target: DPP4
Two Phase II clinical studies have been completed with Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes Mellitus. Phase III clinical studies with trelagliptin in Japan to evaluate its safety and efficacy in a once-weekly oral treatment regimen. Currently, all available DPP-4 inhibitors are dosed once-daily. A once-weekly treatment, such as trelagliptin, would provide patients with a convenient treatment alternative and has the potential to improve treatment compliance.

[1]. Efficacy of SYR-472 in Subjects With Type 2 Diabetes Mellitus
[2]. Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes Mellitus
[3]. Long-term Study of SYR-472
[4]. SYR-472 Open-label Study

Related Products
  • CAS No. :654671-77-9
    Product Name:

    Sitagliptin Phosphate Monohydrate

    Cat No: A000525 View details
  • CAS No. :850649-62-6
    Product Name:

    Alogliptin benzoate

    Cat No: I005101 View details
  • CAS No. :150080-09-4
    Product Name:

    Talabostat mesylate

    Cat No: I009692 View details
  • CAS No. :361442-04-8
    Product Name:


    Cat No: A000518 View details